arrow
M

Michaël Prakesch

University of Toronto
H指数:18
被引数:1,088

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Structure-based discovery of sulfamoyl-ethyl-4-oxo-3,4-dihydro-7H-pyrrolo[2,3-d]pyrimidine amides and sulfonamides as potent B-Cell Lymphoma 6 (BCL6)-BTB inhibitors

基于结构的硫酰氨基-乙基-4-氧代-3,4-二氢-7H-吡咯并[2,3-d]嘧啶酰胺和磺酰胺类化合物的发现及其作为强效B-细胞淋巴瘤6 (BCL6)-BTB抑制剂的用途

2025-11-130
PRE
Molecular glues that inhibit deubiquitylase activity and inflammatory signaling

能够抑制去泛素化酶活性和炎症信号通路的分子胶。

2025-03-170
OA
Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma (vol 64, pg 11129, 2021)
2021-12-281
PREAI
Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma
2021-07-2217
PREAI
Functional characterization of a PROTAC directed against BRAF mutant V600E

针对BRAF突变体V600E的PROTAC的功能表征

2020-08-1091
OAAI
A drug discovery platform to identify compounds that inhibit EGFR triple mutants
2020-02-2436
OAAI
Discovery of OICR-10268: A potent and selective BCL6 inhibitor
2019-07-010
PRE
Structure and mechanism of action of the hydroxy-aryl-aldehyde class of IRE1 endoribonuclease inhibitors
2014-08-28123
OAAI